Abstract
Previous studies in our laboratory identified a negative regulatory domain in the 5'-flanking region of the human CYP1A1 gene containing two negative regulatory elements (NRE). Characterization of one of these elements revealed three nuclear protein binding regions: a 21-bp palindrome with a point of symmetry at -784 and two guanine- and cytosine-rich elements that flank the palindrome. Functional studies suggested the palindrome is critical for transcriptional repression, whereas the guanine- and cytosine-rich sequences play a secondary role. In this study, the interaction between nuclear proteins and the CYP1A1 NRE was further defined. Electrophoretic mobility shift assays (EMSA) indicated that the NRE -784 palindrome alone, but not the guanine- and cytosine-rich sequences minus the palindrome, was capable of specific nuclear protein binding. Competitive cotransfection experiments confirmed this observation in intact cells. Specific residues important for DNA-protein interactions were identified by site-directed mutagenesis and competitive EMSA. The loss of specific protein binding was also correlated with the loss of negative regulatory activity in a transient-expression assay. Finally, competitive EMSA was performed with consensus oligonucleotides for known transcription factors. An NF-Y consensus sequence efficiently competed with the NRE probe for specific nuclear protein binding. EMSA supershift analyses indicate that a protein immunologically related to NF-YB is part of the specific nuclear protein complex binding the human CYP1A1 NRE. These studies have refined our understanding of the sequences critical for the transcriptional repression of human CYP1A1. To our knowledge, this is also the first report implicating a member of the NF-Y transcription factor family in negative gene regulation.
Full Text
The Full Text of this article is available as a PDF (382.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979 Dec 6;282(5739):615–616. doi: 10.1038/282615a0. [DOI] [PubMed] [Google Scholar]
- An G., Hidaka K., Siminovitch L. Expression of bacterial beta-galactosidase in animal cells. Mol Cell Biol. 1982 Dec;2(12):1628–1632. doi: 10.1128/mcb.2.12.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauer E., Guo Z., Ueng Y. F., Bell L. C., Zeldin D., Guengerich F. P. Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem Res Toxicol. 1995 Jan-Feb;8(1):136–142. doi: 10.1021/tx00043a018. [DOI] [PubMed] [Google Scholar]
- Boucher P. D., Hines R. N. In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. Carcinogenesis. 1995 Feb;16(2):383–392. doi: 10.1093/carcin/16.2.383. [DOI] [PubMed] [Google Scholar]
- Boucher P. D., Ruch R. J., Hines R. N. Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J Biol Chem. 1993 Aug 15;268(23):17384–17391. [PubMed] [Google Scholar]
- Chodosh L. A., Baldwin A. S., Carthew R. W., Sharp P. A. Human CCAAT-binding proteins have heterologous subunits. Cell. 1988 Apr 8;53(1):11–24. doi: 10.1016/0092-8674(88)90483-7. [DOI] [PubMed] [Google Scholar]
- Chodosh L. A., Olesen J., Hahn S., Baldwin A. S., Guarente L., Sharp P. A. A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell. 1988 Apr 8;53(1):25–35. doi: 10.1016/0092-8674(88)90484-9. [DOI] [PubMed] [Google Scholar]
- Dorn A., Bollekens J., Staub A., Benoist C., Mathis D. A multiplicity of CCAAT box-binding proteins. Cell. 1987 Sep 11;50(6):863–872. doi: 10.1016/0092-8674(87)90513-7. [DOI] [PubMed] [Google Scholar]
- Fujino T., Gottlieb K., Manchester D. K., Park S. S., West D., Gurtoo H. L., Tarone R. E., Gelboin H. V. Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Cancer Res. 1984 Sep;44(9):3916–3923. [PubMed] [Google Scholar]
- Guengerich F. P. Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol. 1990;25(2):97–153. doi: 10.3109/10409239009090607. [DOI] [PubMed] [Google Scholar]
- Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983 Jun 5;166(4):557–580. doi: 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
- Hasan S., Koda T., Kakinuma M. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem. 1994 Oct 7;269(40):25042–25048. [PubMed] [Google Scholar]
- Hatamochi A., Golumbek P. T., Van Schaftingen E., de Crombrugghe B. A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem. 1988 Apr 25;263(12):5940–5947. [PubMed] [Google Scholar]
- Hines R. N., Mathis J. M., Jacob C. S. Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis. 1988 Sep;9(9):1599–1605. doi: 10.1093/carcin/9.9.1599. [DOI] [PubMed] [Google Scholar]
- Israel D. I., Estolano M. G., Galeazzi D. R., Whitlock J. P., Jr Superinduction of cytochrome P1-450 gene transcription by inhibition of protein synthesis in wild type and variant mouse hepatoma cells. J Biol Chem. 1985 May 10;260(9):5648–5653. [PubMed] [Google Scholar]
- Jaiswal A. K., Gonzalez F. J., Nebert D. W. Comparison of human mouse P1450 upstream regulatory sequences in liver- and nonliver-derived cell lines. Mol Endocrinol. 1987 Apr;1(4):312–320. doi: 10.1210/mend-1-4-312. [DOI] [PubMed] [Google Scholar]
- Kellermann G., Shaw C. R., Luyten-Kellerman M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med. 1973 Nov 1;289(18):934–937. doi: 10.1056/NEJM197311012891802. [DOI] [PubMed] [Google Scholar]
- Kouri R. E., McKinney C. E., Slomiany D. J., Snodgrass D. R., Wray N. P., McLemore T. L. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 1982 Dec;42(12):5030–5037. [PubMed] [Google Scholar]
- Maity S. N., Sinha S., Ruteshouser E. C., de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem. 1992 Aug 15;267(23):16574–16580. [PubMed] [Google Scholar]
- Maity S. N., Vuorio T., de Crombrugghe B. The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5378–5382. doi: 10.1073/pnas.87.14.5378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mantovani R., Pessara U., Tronche F., Li X. Y., Knapp A. M., Pasquali J. L., Benoist C., Mathis D. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J. 1992 Sep;11(9):3315–3322. doi: 10.1002/j.1460-2075.1992.tb05410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLemore T. L., Adelberg S., Czerwinski M., Hubbard W. C., Yu S. J., Storeng R., Wood T. G., Hines R. N., Boyd M. R. Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines. J Natl Cancer Inst. 1989 Dec 6;81(23):1787–1794. doi: 10.1093/jnci/81.23.1787. [DOI] [PubMed] [Google Scholar]
- McLemore T. L., Adelberg S., Liu M. C., McMahon N. A., Yu S. J., Hubbard W. C., Czerwinski M., Wood T. G., Storeng R., Lubet R. A. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst. 1990 Aug 15;82(16):1333–1339. doi: 10.1093/jnci/82.16.1333. [DOI] [PubMed] [Google Scholar]
- Muerhoff A. S., Williams D. E., Masters B. S. Purification and properties of pregnancy-inducible rabbit lung cytochrome P-450 prostaglandin omega-hydroxylase. Methods Enzymol. 1990;187:253–267. doi: 10.1016/0076-6879(90)87030-7. [DOI] [PubMed] [Google Scholar]
- Murray G. I., Foster C. O., Barnes T. S., Weaver R. J., Ewen S. W., Melvin W. T., Burke M. D. Expression of cytochrome P450IA in breast cancer. Br J Cancer. 1991 Jun;63(6):1021–1023. doi: 10.1038/bjc.1991.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993 Jan-Feb;12(1):1–51. doi: 10.1089/dna.1993.12.1. [DOI] [PubMed] [Google Scholar]
- Okey A. B., Riddick D. S., Harper P. A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol Sci. 1994 Jul;15(7):226–232. doi: 10.1016/0165-6147(94)90316-6. [DOI] [PubMed] [Google Scholar]
- Petersen D. D., McKinney C. E., Ikeya K., Smith H. H., Bale A. E., McBride O. W., Nebert D. W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet. 1991 Apr;48(4):720–725. [PMC free article] [PubMed] [Google Scholar]
- Piechocki M. P., Hines R. N. Oligonucleotide design and optimized protocol for site-directed mutagenesis. Biotechniques. 1994 Apr;16(4):702–707. [PubMed] [Google Scholar]
- Pyykkö K., Tuimala R., Aalto L., Perkiö T. Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer? Br J Cancer. 1991 Apr;63(4):596–600. doi: 10.1038/bjc.1991.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Renkawitz R. Transcriptional repression in eukaryotes. Trends Genet. 1990 Jun;6(6):192–197. doi: 10.1016/0168-9525(90)90176-7. [DOI] [PubMed] [Google Scholar]
- Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seed B., Sheen J. Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 1988 Jul 30;67(2):271–277. doi: 10.1016/0378-1119(88)90403-9. [DOI] [PubMed] [Google Scholar]
- Skalnik D. G., Strauss E. C., Orkin S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem. 1991 Sep 5;266(25):16736–16744. [PubMed] [Google Scholar]
- Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
- Sterling K., Weaver J., Ho K. L., Xu L. C., Bresnick E. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells. Mol Pharmacol. 1993 Sep;44(3):560–568. [PubMed] [Google Scholar]
- Waterman M. R., Lund J., Ahlgren R., Wu D., Simpson E. R. Regulation of steroid hydroxylase gene expression and steroid hormone biosynthesis. Biochem Soc Trans. 1990 Feb;18(1):26–28. doi: 10.1042/bst0180026. [DOI] [PubMed] [Google Scholar]